ARALEZ PHARMACEUTICALS INC's ticker is ARLZ and the CUSIP is 03852X100. A total of 47 filers reported holding ARALEZ PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $1,000 | -88.9% | 3,820 | -36.5% | 0.00% | – |
Q1 2018 | $9,000 | 0.0% | 6,020 | 0.0% | 0.00% | – |
Q4 2017 | $9,000 | -52.6% | 6,020 | -27.1% | 0.00% | – |
Q3 2017 | $19,000 | -63.5% | 8,260 | -78.5% | 0.00% | -100.0% |
Q2 2017 | $52,000 | -65.6% | 38,350 | -45.9% | 0.00% | -66.7% |
Q1 2017 | $151,000 | -67.4% | 70,927 | -32.5% | 0.00% | -70.0% |
Q4 2016 | $463,000 | -17.2% | 105,003 | -8.8% | 0.01% | -23.1% |
Q3 2016 | $559,000 | +373.7% | 115,184 | +218.2% | 0.01% | +333.3% |
Q2 2016 | $118,000 | – | 36,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 2,737,140 | $9,033,000 | 7.18% |
DRILL CRAIG A | 584,600 | $1,929,000 | 3.80% |
ARMISTICE CAPITAL, LLC | 2,664,000 | $8,791,000 | 3.35% |
Healthcare Value Capital, LLC | 575,000 | $1,898,000 | 2.30% |
Tiger Legatus Capital Management, LLC | 1,500,000 | $4,950,000 | 1.50% |
Broadfin Capital, LLC | 4,106,990 | $13,553,000 | 1.32% |
Kavi Asset Management, LP | 313,627 | $1,035,000 | 0.83% |
Elk Creek Partners, LLC | 1,514,918 | $4,999,000 | 0.36% |
Par Capital Management | 6,400,000 | $21,120,000 | 0.35% |
Healthcare Value Capital, LLC | 75,000 | $248,000 | 0.30% |